Back
Xencor Vs. 4D Molecular Therapeutics Industry Stock Comparison
Sell
36
XNCR
Xencor
Last Price:
19.96
Seasonality Move:
15.94%
Sell
16
FDMT
4D Molecular Therapeutics
Last Price:
23.21
Seasonality Move:
-20.46%
Sell
36
Xencor (XNCR)
is a Sell
Is Xencor a Buy, Sell or Hold?
- The current Xencor [XNCR] share price is $19.98. The Score for XNCR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- XNCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
16
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy, Sell or Hold?
- The current 4D Molecular Therapeutics [FDMT] share price is $23.25. The Score for FDMT is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- FDMT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
XNCR Stock Price Chart
FDMT Stock Price Chart
What is 4D Molecular Therapeutics's stock price today?
-
The 4D Molecular Therapeutics share price today is $23.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing slight selling pressure.
XNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.81 | Sell |
| Relative Strength Index (14 RSI): | 46.87 | Sell |
| Chaikin Money Flow: | 120837 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.14 - 21.88) | Sell |
| Bollinger Bands (100): | (19.29 - 22.87) | Sell |
FDMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.44 | Sell |
| Relative Strength Index (14 RSI): | 34.11 | Sell |
| Chaikin Money Flow: | -30640 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.57 - 31.31) | Sell |
| Bollinger Bands (100): | (18.43 - 29.93) | Sell |
XNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.9 | Buy |
| 20-day SMA: | 20.11 | Sell |
| 50-day SMA: | 22.01 | Sell |
| 200-day SMA: | 20.92 | Sell |
| 8-day EMA: | 19.28 | Buy |
| 20-day EMA: | 19.99 | Sell |
| 50-day EMA: | 20.86 | Sell |
| 200-day EMA: | 21.84 | Sell |
FDMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.7 | Sell |
| 20-day SMA: | 26.48 | Sell |
| 50-day SMA: | 28.52 | Sell |
| 200-day SMA: | 19.19 | Buy |
| 8-day EMA: | 24.68 | Sell |
| 20-day EMA: | 26.35 | Sell |
| 50-day EMA: | 26.76 | Sell |
| 200-day EMA: | 21.52 | Buy |
Xencor Earnings Growth & XNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.01 per share, a decrease this year of $1.02 per share, and an increase next year of $0.51 per share.
4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.32 per share.
Xencor Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
4D Molecular Therapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||